Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality
Mood stabilisers for women: Always assume she could become pregnant tomorrow
+News
In print
Summer Hiatus
Mood stabilisers for women: Always assume she could become pregnant tomorrow
Saturday 21 December 2019, 06:00 AM

Taking valproate during pregnancy has been banned in Europe
As part of our Summer Hiatus we have selected some Practice pieces from throughout the year that you might like to revisit over the summer. This article links through to ELearning
Healthcare professionals need be more mindful of the use of valproate for women, and particularly in pregnancy. Tanya Wright writes on the subject after a recent difficult consultation with a patient in late pregnancy
Key points, There is strong evidence to show valproate use in pregnancy produces high rates of physical and developmental abnormalities in offspring.
Valproate